Our office remains closed to visitors due to COVID-19 precautionsRead more
Coronavirus (COVID-19) Updates
The College of Registered Nurses of Manitoba is closely monitoring developments in the novel (new) coronavirus (COVID-19) outbreak to ensure that appropriate measures and supports are in place for registered nurses, employers, and the public. The College is actively engaged with provincial health officials on this issue, and will keep RNs informed of any regulatory matters that may arise.
EFFECTIVE APRIL 1, 2020:
Expedited temporary registration process to enable enhanced service provision during COVID-19 pandemic
The College of Registered Nurses of Manitoba (the College) has worked with colleagues in government and has received a ministerial order allowing the College to expedite registration of those who meet registration requirements as outlined in the application.
The College is waiving the application and registration fees for this process, and the Government of Manitoba is covering the cost of professional liability protection.
COVID-19 WORKFORCE RECRUITMENT
Shared Health Manitoba is issuing an urgent call for health care workers, including Registered Nurses to help support our community’s response to the pandemic. If you are currently registered but not currently working, or you have recently obtained temporary registration for pandemic service provision and seeking to be deployed into the workforce, please visit the Shared Health website for a list of current opportunities.
EFFECTIVE DECEMBER 3, 2020
Temporary Pandemic Registration Process for Qualified Internationally Educated Nurses
In light of the current public health emergency, and challenges accessing language testing due to pandemic restrictions, the College has worked with our partners in government and in the health system to obtain a ministerial order authorizing the College to temporarily waive or modify registration requirements for internationally educated applicants meeting specific criteria.
Public Statements by Registered Nurses
The COVID-19 pandemic has put unprecedented strain on our health system, and registered nurses have been at the forefront of that response for over a year. As public health measures continue to evolve and be required to mitigate the spread and impacts of the virus, it is essential that all RNs consider their professional responsibilities when making public statements on this important topic.
COVID-19 Vaccination or Testing Requirements For Designated Persons (September 24, 2021)
On Aug. 24, the Manitoba government announced its intent to release new public health orders related to COVID-19 testing or vaccination for designated front-line public servants including health-care workers (such as registered nurses) providing direct care. The new public health order was issued today and requires rapid testing of designated front-line public servants who are not fully vaccinated. The order comes into effect on October 18, 2021.
Registrants are encouraged to review the public health order and consult with their employer on any applicable requirements, workplace policies and procedures.
Prescribing and Dispensing of Drugs to Treat COVID-19 – Ivermectin (September 21, 2021)
Over the last several months, there have been increasing reports and misleading claims circulating in the community and online regarding the purported use of the veterinary antiparasitic agent ivermectin in the treatment of COVID-19, similar to previous claims surrounding the anti-malarial, antibiotic and antiviral therapies to treat COVID-19 earlier in the pandemic.
The College is urging registrants’ continued diligence in supporting clients with evidence-informed care, and recognizes and appreciates the extraordinary efforts of all RNs, RN(AP)s, and RN(NP)s in upholding patient safety and battling misinformation as the pandemic continues.
NCLEX-RN Exam Writing Delays Due to Public Health Restrictions (May 17, 2021)
The College is aware that some exam writers were recently advised by Pearson VUE that their exam writing date would need to be rescheduled as a result of changes in public health restrictions. Effective May 14, capacity at Pearson VUE testing centres was reduced from 50% to 10%. Currently, the number of impacted individuals appears to be small, but that could change depending on how long the current restrictions remain in place. Appointments remain available in Manitoba, however on a more limited basis due to the current reduced capacity. The College will continue to monitor this situation closely, and provide updates as they become available. For exam writers seeking more information, log in to your Pearson VUE account.
Ministerial order authorizing performance of reserved act (Administering Vaccine by Injection) (June 30, 2021)
The Minister of Health, Seniors and Active Living has issued an order under section 7 of The Regulated Health Professions Act (RHPA) authorizing additional health care workers to perform the reserved act related to administering vaccine by injection in response to COVID-19 under certain conditions. Please read the complete Ministerial Order for more information.
Health care workers authorised by this order must meet a number of conditions to perform the reserved act including being supervised by a member of a regulated health profession who is authorised to perform the reserved act by regulation under the RHPA or by a profession-specific act listed in schedule 2 of the RHPA.
As registered nurses (RNs) are authorised to perform the reserved act by regulation under the RHPA, RNs may be asked to supervise other health care providers assigned to perform this reserved act by their employer. More information about RN responsibilities related to assignment can be found in the Practice Direction: Assignment and Delegation to Unregulated Care Providers.
Ministerial order authorizing performance of reserved act (nasopharyngeal swabbing) (June 3, 2021)
The Minister of Health, Seniors and Active Living has issued an order under section 7 of The Regulated Health Professions Act authorizing additional health care workers to perform the reserved act related to nasopharyngeal swab collection in support of COVID-19 testing under certain conditions. Please read the complete Ministerial Order for more information.
Health care providers authorised through this order may perform nasopharyngeal swab collection as an assignment when supported by their employer. As a member of the health care team, RNs and RN(NP)s may take on roles, such as educator or supervisor, when working in collaboration with other providers to support COVID-19 testing.
Practice expectations related to collaborative care and assignment to unregulated care providers can be found in the following documents:
Prescribing and Dispensing of Drugs to Treat COVID-19 – Oral Dexamethasone (June 24, 2020)
Recently, the results of a clinical trial involving dexamethasone for the treatment of COVID-19 in severely ill patients have been announced in the media. As a result, prescribers may encounter patients in the community seeking dexamethasone for personal use, as many healthcare professionals encountered with hydroxychloroquine. The College is urging registrants’ continued diligence in supporting clients with evidence-informed care. Please read this joint communication from the College of Registered Nurses of Manitoba, College of Pharmacists of Manitoba and College of Physicians and Surgeons of Manitoba.
Ensuring Safe Access to M3P Prescriptions for Patients During COVID-19 Outbreak (April 17, 2020)
The College of Physicians and Surgeons of Manitoba (CPSM), College of Registered Nurses of Manitoba (CRNM) and the College of Pharmacists of Manitoba (CPhM) have received several inquiries regarding measures to ensure safe patient access to Manitoba Prescribing Practices Program (M3P) drugs during the COVID-19 outbreak. Several registrants have also voiced their concern about maintaining safe prescribing practices while implementing social distancing where possible.
Inquiries have also been received from prescribers regarding the appropriateness of virtual and phone visits for patients who require a M3P prescription.
In response to these inquiries, the CPSM, CRNM and CPhM are providing the following guidance when it comes to drugs that usually require an M3P form.